---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-069218"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:25:20.592034+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics discloses minimal SVB exposure; less than 1% of cash at SVB

## Summary
- SVB closed by California DFPI on March 10; FDIC appointed receiver.
- U.S. Treasury, Fed, FDIC: all depositors fully protected; funds accessible March 13.
- Nurix's SVB account holds less than 1% of total cash, equivalents, and marketable securities.
- Remaining cash held at other large, global financial institutions.
- Company believes exposure is immaterial and funds will be fully available.

## SEC filing metadata
- accession: 0001193125-23-069218
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/0001193125-23-069218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312523069218/d484325d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-069218
- JSON: https://secwatch.observer/filing/0001193125-23-069218.json
- Plain text: https://secwatch.observer/filing/0001193125-23-069218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.